▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Scipher Medicine® Launches a New Approach to Discover Treatment-Response-Predicting Biomarkers for Complex Diseases

Scipher Medicine, a company focused on proprietary AI and network biology platform solutions to transform patient care, has launched a new approach to develop biomarkers following the publication of t...

Business Wire

WALTHAM, Mass.: Scipher Medicine, a company focused on proprietary AI and network biology platform solutions to transform patient care, has launched a new approach to develop biomarkers following the publication of the novel, patent-pending framework PRoBeNet (Predictive Response Biomarkers using Network medicine).

“I am thrilled to be launching PRoBeNet to enable an accelerated path for early biomarker development in complex diseases,” said Reg Seeto, MBBS, President and CEO. “This product further expands our portfolio of offerings within companion and complementary diagnostics which have utility in late stage drug development, precision medicine, and, ultimately, improve patient outcomes.”

PRoBeNet addresses the ongoing challenge with precision medicine’s ability to transform complex autoimmune-disease treatment. The key development challenges to accelerated biomarker development are limited data availability and small sample sizes. Scipher’s novel framework solution addresses these issues using AI and network biology to identify biomarkers of therapy response with inputs from therapy-targeted proteins and disease-specific molecular signatures with our human interactome, which is an underlying network of interactions among cellular components.

PRoBeNet has now been validated across a spectrum of autoimmune disease states including rheumatoid arthritis, ulcerative colitis and Crohn’s disease, with an approved and investigational drug. PRoBeNet can also be generalized to other complex diseases, and drugs in different phases of development if the treatment-targeted proteins and appropriate disease-signature molecules are known.

About Scipher Medicine
Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectra™, a proprietary network medicine platform, Scipher commercializes tests revealing a person’s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. Scipher partners with leading payers, healthcare providers, and pharmaceutical companies to bring solutions to patients across diseases. To learn more about Scipher visit sciphermedicine.com and follow Scipher Medicine on Facebook, X, and LinkedIn.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Dronus gets a strategic investment by Eni Next

Eni's VC company invest in the Italian drone company to develop new solutions for industrial plants monitoring

Technology Reply wins the 2024 Oracle Partner Awards - Europe South Innovation

Oracle recognizes Technology Reply’s ability to develop and deliver pioneering solutions through partnering with Oracle

25 Italian Startups Will Be Present at Expand North Star 2024

Scheduled for October, the world's largest startup event will bring together more than 2,000 exhibitors in Dubai, UAE

Most read

24 Promising Korean Tech Companies at TechCrunch Disrupt 2024

TechCrunch Disrupt 2024 will feature cutting-edge technology from 24 tech startups from South Korea. The Korea Pavilion is presented by Korea Trade-Investment…

Audit & Beyond Hosts Record Number of Attendees, Includes Launch of Powerful…

2024 AUDIT & BEYOND CONFERENCE — AuditBoard, the leading cloud-based platform transforming audit, risk, compliance, and ESG management, wrapped up…

University of Phoenix Launches New Career-Focused Skill Pathways in Practical…

In response to the growing demand for AI skills in the workforce, University of Phoenix is excited to announce the launch of new career-focused skill…

$16.4 Billion AI in Wound Care Market Industry Trends and Global Forecasts,…

The "AI in Wound Care Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Wound, Type of Acute Wound, Type of Chronic Wound,…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!